Published in
Esmo Open, Esmo Open, 4(4), p. e000519, 2019
DOI: 10.1136/esmoopen-2019-000519
Links
Tools
Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer
Journal article published in 2019 by
Claudia Cardone 
,
Erika Martinelli,
Teresa Troiani,
Vincenzo Sforza ,
Anna Nappi,
Vincenzo Montesarchio,
Maria Biglietto,
Filomena Calabrese,
Roberto Bordonaro,
Stefano Cordio,
Giacomo Bregni,
Antonio Febbraro,
Rocio Garcia-Carbonero,
Jaime Feliu,
Andrés Cervantes
and other authors.
,
Erika Martinelli,
Teresa Troiani,
Vincenzo Sforza ,
Anna Nappi,
Vincenzo Montesarchio,
Maria Biglietto,
Filomena Calabrese,
Roberto Bordonaro,
Stefano Cordio,
Giacomo Bregni,
Antonio Febbraro,
Rocio Garcia-Carbonero,
Jaime Feliu,
Andrés Cervantes
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 